Cambrian Biopharma Stock
Cambrian is a distributed development company building therapeutics to lengthen health span.
Sign up today and learn more about Cambrian Biopharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cambrian Biopharma Stock
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Funding History
| February 2021 | $60.0M |
|---|---|
| October 2021 | $100M |
Management
Board Member
Martin Chavez
Executive Vice President, Chemistry
Dennis Yamashita
Board Member
Paul Farr
Scientist in Residence
Daisy Robinton
Board Member
Brenton Saunders
Board Member
Steve Jurvetson
EVP, Clinical Development
Ruth Thieroff-Ekerdt
Board Member
Maryanna Saenko
Founder and CEO
James Peyer
Press
TechCrunch - May, 3 2023
Hear how Cambrian BioPharma is reinventing drug (and drug company) developmentTechCrunch - Apr, 26 2023
Hear how Cambrian BioPharma is reinventing drug (and drug company) developmentEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
